Harmonising ER+ Breast cancer
时间: 2024-06-04 22:06:11 浏览: 13
"Harmonising ER+ breast cancer" refers to the process of standardizing the way estrogen receptor positive (ER+) breast cancer is classified and treated. ER+ breast cancer is a type of breast cancer that tests positive for the presence of estrogen receptors, which promote the growth of cancer cells. Harmonizing ER+ breast cancer involves ensuring that healthcare providers use consistent criteria for diagnosing and staging the cancer, as well as providing standardized treatment options based on the stage and characteristics of the cancer. This can lead to better outcomes for patients and more efficient use of healthcare resources.
相关推荐
![zip](https://img-home.csdnimg.cn/images/20210720083736.png)
![zip](https://img-home.csdnimg.cn/images/20210720083736.png)
![zip](https://img-home.csdnimg.cn/images/20210720083736.png)
![zip](https://img-home.csdnimg.cn/images/20210720083736.png)
![zip](https://img-home.csdnimg.cn/images/20210720083736.png)
![7z](https://img-home.csdnimg.cn/images/20210720083312.png)